1. Home
  2. PTGX vs MHO Comparison

PTGX vs MHO Comparison

Compare PTGX & MHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • MHO
  • Stock Information
  • Founded
  • PTGX 2006
  • MHO 1976
  • Country
  • PTGX United States
  • MHO United States
  • Employees
  • PTGX N/A
  • MHO N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • MHO Homebuilding
  • Sector
  • PTGX Health Care
  • MHO Consumer Discretionary
  • Exchange
  • PTGX Nasdaq
  • MHO Nasdaq
  • Market Cap
  • PTGX 2.9B
  • MHO 3.1B
  • IPO Year
  • PTGX 2016
  • MHO 1986
  • Fundamental
  • Price
  • PTGX $47.47
  • MHO $106.57
  • Analyst Decision
  • PTGX Strong Buy
  • MHO Strong Buy
  • Analyst Count
  • PTGX 8
  • MHO 3
  • Target Price
  • PTGX $66.50
  • MHO $158.67
  • AVG Volume (30 Days)
  • PTGX 789.1K
  • MHO 211.1K
  • Earning Date
  • PTGX 05-06-2025
  • MHO 04-23-2025
  • Dividend Yield
  • PTGX N/A
  • MHO N/A
  • EPS Growth
  • PTGX N/A
  • MHO 9.13
  • EPS
  • PTGX 0.86
  • MHO 18.93
  • Revenue
  • PTGX $207,801,000.00
  • MHO $4,434,060,000.00
  • Revenue This Year
  • PTGX N/A
  • MHO $0.74
  • Revenue Next Year
  • PTGX $50.30
  • MHO $0.62
  • P/E Ratio
  • PTGX $55.04
  • MHO $5.63
  • Revenue Growth
  • PTGX N/A
  • MHO 8.69
  • 52 Week Low
  • PTGX $27.00
  • MHO $100.22
  • 52 Week High
  • PTGX $60.60
  • MHO $176.18
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 58.60
  • MHO 44.80
  • Support Level
  • PTGX $45.43
  • MHO $105.74
  • Resistance Level
  • PTGX $46.80
  • MHO $109.84
  • Average True Range (ATR)
  • PTGX 1.54
  • MHO 3.04
  • MACD
  • PTGX 0.34
  • MHO -0.28
  • Stochastic Oscillator
  • PTGX 94.26
  • MHO 18.72

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About MHO M/I Homes Inc.

M/I Homes Inc is an American construction company that focuses on residential construction. It consists of two distinct operations: homebuilding and financial services. The homebuilding operations are spread into the Midwest, Mid-Atlantic, and Southern regions, and the financial services operations support homebuilding operations by providing mortgage loans and title services to the customers of homebuilding operations. Homebuilding operations comprise a predominant portion of the revenue. The company builds homes and communities that target entry-level, move-up, and luxury homebuyers.

Share on Social Networks: